David B Meya
David B Meya is an expert in Infectiology at Mulago Hospital (Uganda). As of October 2026, ScienceLeadR ranks David B Meya in the top 1% of experts worldwide for Meningitis, Neuroinflammatory Diseases and Mycoses. David B Meya has authored 372 publications, the most recent in 2026, and is an investigator in 12 clinical trials, 3 of them ongoing. SLR score: 1,442 (community average: 125). How the SLR is computed.
LeadR Profile
Infectiology
Subspecialties: Neurology - Public Health - Immunology
Main Topics
Publications and Clinical Studies
Profile data updated on
Organizations
Career arc: 2007 - 2026
Number : 372
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Birth and clinical outcomes of pregnant participants with advanced HIV disease. PMID 42900018 — cd4 lymphocyte count, cells, pregnancy, opportunistic infections, parturition, acquired immunodeficiency syndrome, tuberculosis, therapeutics, infections | J Acquir Immune Defic Syndr | 2026 | 0 |
| Review of Risk Factors and Factors Influencing Outcomes of Cryptococcal Meningitis in Persons Living with HIV. PMID 42639513 — mortality, meningitis, meningitis, cryptococcal, risk factors, therapeutics | Infect Drug Resist | 2026 | 0 |
| Concordance Between Fingerprick and Venous Whole Blood CD4 Counts Using the Visitect CD4 Advanced disease platform. PMID 42636100 — cd4 lymphocyte count, blood, communicable diseases | J Infect Dis | 2026 | 1 |
| Once-Daily Dolutegravir-Based Antiretroviral Therapy Among Adults With Advanced HIV Disease Receiving 1 Month of Daily Rifapentine and Isoniazid for Tuberculosis-Preventive Therapy and Fluconazole for Treatment of Cryptococcal Meningitis: Results of a Pharmacokinetic Study. PMID 42597883 — cd4 lymphocyte count, pharmaceutical preparations, fluconazole, meningitis, hiv, meningitis, cryptococcal, tuberculosis, therapeutics, isoniazid, plasma, pharmacokinetics, dolutegravir | Open Forum Infect Dis | 2026 | 0 |
| Bilateral Pathological Femoral Fractures Secondary to Long-Term Tenofovir Disoproxil Fumarate-Induced Osteomalacia in a Woman Living with HIV: A Case Report. PMID 42583030 — tenofovir, alkaline phosphatase, osteomalacia, femoral fractures, hypophosphatemia, vitamins, pain, fumarates, phosphoric monoester hydrolases, therapeutics, fractures, spontaneous, abacavir | Int Med Case Rep J | 2026 | 1 |
Clinical Studies 12
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
3 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| BPaLMZ for TB Meningitis NCT07227779 — moxifloxacin, tuberculosis, meningeal, latent tuberculosis, linezolid, meningitis, tuberculosis, therapeutics, pyrazinamide | Phase 2 | Recruiting | 2026 |
| Platform Trial For Cryptococcal Meningitis (PLATFORM CM) NCT06666322 — injections, mortality, pharmaceutical preparations, fluconazole, sterols, flucytosine, meningitis, acquired immunodeficiency syndrome, hiv, meningitis, cryptococcal, azoles, cryptococcus, amphotericin b, therapeutics, infections | Phase 2/Phase 3 | Recruiting | 2025 |
| Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial 3 NCT05541107 — meningitis, meningitis, cryptococcal, amphotericin b | Phase 3 | Not yet recruiting | 2023 |
LeadR Networks
Main global connection map